MAIA
Ticker
MAIA Biotechnology, Inc.
MAIA · Healthcare · MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targete…MAIA Biotechnology, Inc. (MAIA), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 3 purchases and 0 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 14 and filed Sep 15. The most active filer was Ramiro Guerrero with 3 filings.
Add to watchlistFilings, ttm
3
3 buys · 0 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$301K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Sep 14
Filed Sep 15
ADViAverage daily dollar volume
$915K
market data
Share price · 12M
$1.33 (-12.5%)
Adjusted for splits and dividends.
Volume by month
Buys $994K
Sells $0
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
RGRecent filings
Vlad VitocPURCHASE
Chief Executive Officer
$100K73,000 sh × $1.37
Exec Sep 14
Filed Sep 15 · 6:33 AM ET Vlad VitocPURCHASE Chief Executive Officer $101K
72,700 sh × $1.39
Exec Jun 1
Filed Jun 2 · 9:02 AM ET Stan SmithPURCHASE Director $100K
75,000 sh × $1.34
Exec Jun 1
Filed Jun 2 · 9:01 AM ET Ramiro GuerreroPURCHASE Director $110K
73,333 sh × $1.50
Exec Feb 24 2025
Filed Mar 5 2025 · 5:30 PM ET † Ramiro GuerreroPURCHASE Director $110K
73,333 sh × $1.50
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET Stan SmithPURCHASE Director $251K
100,000 sh × $2.51
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET Ramiro GuerreroPURCHASE Director $222K
88,534 sh × $2.51
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET